Cambridge Science Pharmaceuticals Cps Expects Final Approval Revolutionary Weight Loss Dru Q34697042

cambridge science pharmaceuticals (CPS) expects final approvalfor its revolutionary weight loss drug, metabical. metabical willbe the weight loss drug with FDA approval that is also clinicallyproven to be effective for moderately overweight people. BarbaraPrintup, Senior marketing Director for CSP, must develop thepositioning strategy and marketing communications plan onpreparation for the launch of the new drug. Printup must considerthe consumer decision-making process and the interaction betweenthe consumer who purchases the drug and the health care providerwho prescribes the medication. despite promising medical studiesand consumer research, poor positioning of the drug in the higlycompetive market for weight-loss solution could spell disaster. 1.briefly explain the situation. 2. state the symptoms 3. identifythe probable problem (if many are possible, choose one) 4.Formulate the main question of the study 5. formulate resaerchobjectives 6. what could be the research hypotheses?